Abarca Health

𝐓𝐡𝐞 𝐏𝐁𝐌 𝐒𝐡𝐚𝐤𝐞𝐨𝐮𝐭 𝐢𝐬 𝐆𝐚𝐢𝐧𝐢𝐧𝐠 𝐌𝐨𝐦𝐞𝐧𝐭𝐮𝐦 Abarca Health and LucyRx just announced their merger. As we discussed in our April webinar, the PBM market is entering a significant consolidation phase. LucyRx has already acquired two smaller competitors in 2024 and 2025. Many smaller PBMs still rely on the Big Three PBMs for critical infrastructure, including claims processing, pharmacy networks, rebate administration, and other core services. At the same time, the growing complexity of state and federal regulation is creating additional operational and compliance burdens. Thanks, CAA! 🙃 Those costs will fall most heavily on smaller PBMs that lack the scale, capital resources, and integrated capabilities of the industry's largest players. Meanwhile, transparency is becoming less of a differentiator. Or, as Syndrome put it in The Incredibles: “When everyone’s super, no one will be.” The result? More pressure on smaller PBMs and, likely, more consolidation across the sector. Here's the announcement: drugch.nl/4uFZJDG